BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16140283)

  • 1. Semantic priming after ketamine acutely in healthy volunteers and following chronic self-administration in substance users.
    Morgan CJ; Rossell SL; Pepper F; Smart J; Blackburn J; Brandner B; Curran HV
    Biol Psychiatry; 2006 Feb; 59(3):265-72. PubMed ID: 16140283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and chronic effects of ketamine on semantic priming: modeling schizophrenia?
    Stefanovic A; Brandner B; Klaassen E; Cregg R; Nagaratnam M; Bromley LM; Das RK; Rossell SL; Morgan CJ; Curran HV
    J Clin Psychopharmacol; 2009 Apr; 29(2):124-33. PubMed ID: 19512973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consequences of chronic ketamine self-administration upon neurocognitive function and psychological wellbeing: a 1-year longitudinal study.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2010 Jan; 105(1):121-33. PubMed ID: 19919593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using ketamine to model semantic deficits in schizophrenia.
    Neill E; Rossell SL; McDonald S; Joshua N; Jansen N; Morgan CJ
    J Clin Psychopharmacol; 2011 Dec; 31(6):690-7. PubMed ID: 22020346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls.
    Morgan CJ; Muetzelfeldt L; Curran HV
    Addiction; 2009 Jan; 104(1):77-87. PubMed ID: 19133891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyper-priming in cannabis users: a naturalistic study of the effects of cannabis on semantic memory function.
    Morgan CJ; Rothwell E; Atkinson H; Mason O; Curran HV
    Psychiatry Res; 2010 Apr; 176(2-3):213-8. PubMed ID: 20122742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beyond the K-hole: a 3-year longitudinal investigation of the cognitive and subjective effects of ketamine in recreational users who have substantially reduced their use of the drug.
    Morgan CJ; Monaghan L; Curran HV
    Addiction; 2004 Nov; 99(11):1450-61. PubMed ID: 15500598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic modulation of semantic priming in healthy volunteers.
    Roesch-Ely D; Weiland S; Scheffel H; Schwaninger M; Hundemer HP; Kolter T; Weisbrod M
    Biol Psychiatry; 2006 Sep; 60(6):604-11. PubMed ID: 16603132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers.
    Morgan CJ; Mofeez A; Brandner B; Bromley L; Curran HV
    Neuropsychopharmacology; 2004 Jan; 29(1):208-18. PubMed ID: 14603267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later.
    Uhlhaas PJ; Millard I; Muetzelfeldt L; Curran HV; Morgan CJ
    J Psychopharmacol; 2007 May; 21(3):347-52. PubMed ID: 17591661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.
    Krystal JH; Karper LP; Seibyl JP; Freeman GK; Delaney R; Bremner JD; Heninger GR; Bowers MB; Charney DS
    Arch Gen Psychiatry; 1994 Mar; 51(3):199-214. PubMed ID: 8122957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.
    Gouzoulis-Mayfrank E; Heekeren K; Neukirch A; Stoll M; Stock C; Obradovic M; Kovar KA
    Pharmacopsychiatry; 2005 Nov; 38(6):301-11. PubMed ID: 16342002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of semantic processing abnormalities in schizotypy using an indirect semantic priming task.
    Johnston AE; Rossell SL; Gleeson JF
    J Nerv Ment Dis; 2008 Sep; 196(9):694-701. PubMed ID: 18791431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later.
    Curran HV; Morgan C
    Addiction; 2000 Apr; 95(4):575-90. PubMed ID: 10829333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does ketamine mimic aspects of schizophrenic speech?
    Covington MA; Riedel WJ; Brown C; He C; Morris E; Weinstein S; Semple J; Brown J
    J Psychopharmacol; 2007 May; 21(3):338-46. PubMed ID: 17591660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypericum extract reverses S-ketamine-induced changes in auditory evoked potentials in humans - possible implications for the treatment of schizophrenia.
    Murck H; Spitznagel H; Ploch M; Seibel K; Schaffler K
    Biol Psychiatry; 2006 Mar; 59(5):440-5. PubMed ID: 16165104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is semantic processing impaired in individuals with high schizotypy?
    Morgan CJ; Bedford NJ; O'Regan A; Rossell SL
    J Nerv Ment Dis; 2009 Apr; 197(4):232-8. PubMed ID: 19363378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining and updating semantic context in schizophrenia: an investigation of the effects of multiple remote primes.
    Chenery HJ; Copland DA; McGrath J; Savage G
    Psychiatry Res; 2004 May; 126(3):241-52. PubMed ID: 15157750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.